BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27233934)

  • 21. Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine: a multicenter study.
    Tateishi U; Tatsumi M; Terauchi T; Ishizawa K; Ogura M; Tobinai K
    Cancer Sci; 2011 Feb; 102(2):414-8. PubMed ID: 21156007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mantle cell lymphoma: primary oral presentation.
    Ainscough S; Power AM; Brown AN
    Ann R Coll Surg Engl; 2017 Jan; 99(1):e13-e14. PubMed ID: 27551901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 18F-FDG PET for Measurement of Response and Prediction of Outcome to Relapsed or Refractory Mantle Cell Lymphoma Therapy with Bendamustine-Rituximab.
    Lamonica D; Graf DA; Munteanu MC; Czuczman MS
    J Nucl Med; 2017 Jan; 58(1):62-68. PubMed ID: 27469362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome.
    Karam M; Ata A; Irish K; Feustel PJ; Mottaghy FM; Stroobants SG; Verhoef GE; Chundru S; Douglas-Nikitin V; Oliver Wong CY; Brepoels LM
    Nucl Med Commun; 2009 Oct; 30(10):770-8. PubMed ID: 19657307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Renal or perirenal malignant lymphoma: report of three cases].
    Yoshimura K; Kawakita M; Onishi H; Hashimura T; Takeuchi H; Yoshida O; Fukuhara S
    Hinyokika Kiyo; 1993 Sep; 39(9):831-6. PubMed ID: 8213378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nodal status of malignant lymphoma in pelvic and retroperitoneal lymphatic pathways: PET/CT.
    Tateishi U; Terauchi T; Inoue T; Tobinai K
    Abdom Imaging; 2010 Apr; 35(2):232-40. PubMed ID: 19370298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurological picture. FDG-PET in meningeal lymphomatosis.
    Shinohara M; Kosaka S; Okamura T; Yamamoto T
    J Neurol Neurosurg Psychiatry; 2007 Sep; 78(9):974. PubMed ID: 17702776
    [No Abstract]   [Full Text] [Related]  

  • 28. Mantle cell lymphoma of the maxillary sinus invading the orbit.
    Nagel-Esposito AD; Kawasaki B; Jew R; Fujimoto L
    Optometry; 2011 Jan; 82(1):22-31. PubMed ID: 21146791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MDCT of extranodal mantle cell lymphoma: a single institute experience.
    Baheti AD; Tirumani SH; Sewatkar R; Sachin SS; Shinagare AB; Ramaiya NH
    Abdom Imaging; 2015 Aug; 40(6):1693-9. PubMed ID: 25724714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oesophageal involvement in mantle cell lymphoma.
    Santra G
    Singapore Med J; 2010 Dec; 51(12):e201-3. PubMed ID: 21221493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin Involvement of Mantle Cell Lymphoma May Mimic Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type.
    Wehkamp U; Pott C; Unterhalt M; Koch K; Weichenthal M; Klapper W; Oschlies I
    Am J Surg Pathol; 2015 Aug; 39(8):1093-101. PubMed ID: 26034867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
    Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF
    Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mantle cell lymphoma and diffuse large B-cell lymphoma of the testis: a unique case of composite non-Hodgkin lymphoma.
    Andhavarapu S; Crozier JA; Jiang L; Sher T
    Eur J Haematol; 2014 Dec; 93(6):537-42. PubMed ID: 24750331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Squamous cell carcinoma of the right kidney on FDG PET-CT.
    Ho L; Modarresifar H; Henderson R
    Clin Nucl Med; 2008 Dec; 33(12):892-3. PubMed ID: 19033801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mantle Cell Lymphoma Presenting as a Subcutaneous Soft Tissue Mass With an Unusual Appearance.
    Cherukuri AR; Kalia V; Sturtevant NV; DeStigter KK
    Ultrasound Q; 2017 Mar; 33(1):101-102. PubMed ID: 28081018
    [No Abstract]   [Full Text] [Related]  

  • 36. Minimal change disease associated with newly diagnosed mantle cell lymphoma.
    Khow KS; Yong AS; Yong TY; Kuss BJ; Barbara JA; Li JY
    Ren Fail; 2014 May; 36(4):634-7. PubMed ID: 24502759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging by ¹⁸F-FDG PET/CT of diffuse large B-cell lymphoma with cellulitis.
    Zhang Y; Li B; Cai L; Shi H; Hou J
    Hell J Nucl Med; 2015; 18(3):271-2. PubMed ID: 26574700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes.
    Mosavi F; Wassberg C; Selling J; Molin D; Ahlström H
    Clin Radiol; 2015 Nov; 70(11):1229-36. PubMed ID: 26208992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case report of misdiagnosed mantle cell lymphoma].
    Yu H; Xu W; Wu YJ; Cheng YX; Qiu HR; Zhang SJ; Sheng RL; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):1112-6. PubMed ID: 17956702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.